Impacting Global Health Delivery Through Advocacy: The Case of Losartan

Highlights

• The WHO’s EML improves medicine access.
• Anyone can lobby to add a medicine to the EML, so we added losartan in 2017.
• Evidence now shows losartan is more impactful than previously realized.
• You too can use the EML to effect policy change—by adding to or amending it.
• Also, you can hold governments accountable to keep EML medicines on their shelves.